Identification of missense mutations in the SRD5A2 gene from patients with steroid 5α‐reductase 2 deficiency
- 1 March 2000
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 52 (3) , 383-387
- https://doi.org/10.1046/j.1365-2265.2000.00941.x
Abstract
BACKGROUND AND OBJECTIVE Mutations of the steroid 5α-reductase type 2 (SRD5A2) gene in karyotypic males result in a spectrum of external genitalia phenotypes ranging from complete female to nearly complete male. Here we performed genomic DNA analyses from individuals bearing the enzyme deficiency in order to detect the molecular abnormalities. PATIENTS Four unrelated 46,XY patients of Mexican origin with ambiguous external genitalia were studied. A fertile, phenotypically normal male was also included. MEASUREMENTS Coding sequence abnormalities of the SRD5A2 gene were assessed by exon-specific polymerase chain reaction, single-stranded conformational polymorphism and sequencing analysis. RESULTS Five different missense mutations (two of them novel mutations) were identified. Three subjects presented homozygous single base mutations. These were located at exon 2 (G115D), exon 4 (P212R) and exon 5 (R246Q), and such changes have been described previously. The fourth patient was a compound heterozygote who presented two mutations located in exons 1 and 2. We found a hitherto unreported G → A transition at the second nucleotide of codon 85 in exon 1 (GGC → GAC), substituting glycine for aspartic acid (G85D). This patient also presented an identical alteration at codon 115 of exon 2, which was carried by his father (G115D). Finally, in another subject who was included originally as a control, we found a C → A transversion (yet undescribed) at codon 245 in exon 5 (S245Y). CONCLUSIONS Four different single base mutations that cause amino acid substitutions were detected in the steroid 5α-reductase type 2 gene of affected individuals. One patient and a normal control had two previously undescribed mutations. Although in the latter individual we cannot exclude the possibility that the base change is a genetic polymorphism, the molecular screening of 100 chromosomes suggests strongly that the change at codon 245 does represent a heterozygous mutation. Further studies, including the recreation of the mutations, will help to reveal the biochemical consequences resulting from these changes.Keywords
This publication has 23 references indexed in Scilit:
- Homozygous mutation (A228T) in the 5?-reductase type 2 gene in a boy with 5?-reductase deficiency: Genotype-phenotype correlationsAmerican Journal of Medical Genetics, 1998
- A Recurrent Missense Mutation in the KAL Gene in Patients with X-Linked Kallmann's SyndromeJournal of Clinical Endocrinology & Metabolism, 1998
- Molecular analysis of the 5α-steroid reductase type 2 gene in a family with deficiency of the enzymeAmerican Journal of Medical Genetics, 1997
- A new deletion of the 5α‐reductase type 2 gene in a Turkish family with 5α‐reductase deficiencyClinical Endocrinology, 1995
- Molecular study of the 5 alpha-reductase type 2 gene in three European families with 5 alpha-reductase deficiencyJournal of Clinical Endocrinology & Metabolism, 1995
- The high frequency of the — 6G → A factor IX promoter mutation is the result both of a founder effect and recurrent mutation at a CpG dinucleotideBritish Journal of Haematology, 1995
- Natural Mutagenesis Study of the Human Steroid 5.alpha.-Reductase 2 IsoenzymeBiochemistry, 1994
- Unusual length polymorphism in human steroid 5α-reductase type 2 gene (SRD5A2)Human Molecular Genetics, 1993
- Molecular genetics of steroid 5 alpha-reductase 2 deficiency.Journal of Clinical Investigation, 1992